- Home
- BAX
as 07-26-2024 4:00pm EST
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
| Founded: | 1931 | Country: | United States |
| Employees: | N/A | City: | DEERFIELD |
| Market Cap: | 17.2B | IPO Year: | N/A |
| Target Price: | $42.60 | AVG Volume (30 days): | 5.0M |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $31.01 - $47.51 | Next Earning Date: | 08-06-2024 |
| Revenue: | $14,892,000,000 | Revenue Growth: | 2.98% |
| Revenue Growth (this year): | 3.06% | Revenue Growth (next year): | 3.64% |
Stock Insider Trading Activity of Baxter International Inc. (BAX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mason Jeanne K | BAX | EVP, Chief HR Officer | Mar 1 '24 | Sell | $40.61 | 64,488 | $2,618,857.68 | 142,290 | SEC Form 4 |
Latest Baxter International Inc. News
BAX Breaking Stock News: Dive into BAX Ticker-Specific Updates for Smart Investing
Bloomberg
3 days ago
Ares, HPS Line Up $3 Billion Debt for Baxter Unit Bid
Simply Wall St.
4 days ago
Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Business Wire
9 days ago
Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
Business Wire
10 days ago
Baxter Declares Quarterly Dividend
MT Newswires
12 days ago
Update: Morgan Stanley Downgrades Baxter International to Underweight From Equalweight, Cuts Price Target to $30 From $39
MT Newswires
12 days ago
Morgan Stanley Downgrades Baxter International to Underweight From Equalweight, Price Target is $30
Zacks
14 days ago
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks
15 days ago
Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?
Compare BAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BAX Baxter International Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.